{"id":9351,"date":"2025-12-09T14:29:55","date_gmt":"2025-12-09T11:29:55","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9351"},"modified":"2025-12-09T14:29:56","modified_gmt":"2025-12-09T11:29:56","slug":"potassium-enriched-salt-in-hypertension-management-hypertension-news-dec-2025","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/potassium-enriched-salt-in-hypertension-management-hypertension-news-dec-2025\/","title":{"rendered":"Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025)"},"content":{"rendered":"<div>Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025)<\/div>\n<div><\/div>\n<div>1.\u2060 \u2060Background: Why Potassium-Enriched Salt?<\/div>\n<div><span> \u2022 High sodium intake remains a major global driver of hypertension, CVD, and premature death.<\/span><\/div>\n<div><span> \u2022 No country is on track to meet WHO salt-reduction targets (2025\/2030).<\/span><\/div>\n<div><span> \u2022 Low potassium intake is an under-recognized but equally important BP risk factor.<\/span><\/div>\n<div><span> \u2022 Most populations consume far below the WHO potassium recommendation (3.5 g\/day).<\/span><\/div>\n<div><\/div>\n<div>2.\u2060 \u2060What Is Potassium-Enriched Salt?<\/div>\n<div><span> \u2022 Regular salt with part of NaCl replaced by KCl (e.g., 75% NaCl \/ 25% KCl).<\/span><\/div>\n<div><span> \u2022 Maintains salty taste \u2192 increases acceptability.<\/span><\/div>\n<div><span> \u2022 Available as \u201cLo Salt,\u201d \u201cLite Salt,\u201d \u201cHeart Salt,\u201d etc.<\/span><\/div>\n<div><span> \u2022 Designed for 1:1 replacement with regular salt.<\/span><\/div>\n<div><\/div>\n<div>3.\u2060 \u2060Evidence for BP &amp; Cardiovascular Benefit<\/div>\n<div><span> \u2022 Dual mechanism: \u2193 sodium intake + \u2191 potassium intake.<\/span><\/div>\n<div><span> \u2022 Strong evidence from systematic reviews and the landmark SSaSS Trial (NEJM) showing:<\/span><\/div>\n<div>\u2714 Lower BP<\/div>\n<div>\u2714 Fewer strokes<\/div>\n<div>\u2714 Reduced cardiovascular events and mortality<\/div>\n<div><span> \u2022 WHO 2025 Global Hypertension Report formally recommends potassium-enriched salt.<\/span><\/div>\n<div><\/div>\n<div>4.\u2060 \u2060Guideline Positioning (2024\u20132025)<\/div>\n<div><span> \u2022 Historically underrepresented: only 4 of 32 guidelines mentioned salt substitutes (2024 review).<\/span><\/div>\n<div><span> \u2022 Now explicitly recommended by:<\/span><\/div>\n<div>\u2714 2024 ESC Hypertension Guidelines<\/div>\n<div>\u2714 2025 ACC\/AHA Hypertension Guidelines<\/div>\n<div><span> \u2022 Growing international endorsement.<\/span><\/div>\n<div><\/div>\n<div>5.\u2060 \u2060Safety and Hyperkalemia Concerns<\/div>\n<div><span> \u2022 Main concern: potential hyperkalemia in patients with CKD, or those on<\/span><\/div>\n<div>\u2022\u2060\u00a0 \u2060potassium supplements<\/div>\n<div>\u2022\u2060\u00a0 \u2060potassium-sparing diuretics<\/div>\n<div><span> \u2022 Trials show:<\/span><\/div>\n<div>\u2022\u2060\u00a0 \u2060No increase in clinical harm, even in CKD-inclusive studies.<\/div>\n<div>\u2022\u2060\u00a0 \u2060Some biochemical hyperkalemia noted, but CV benefits remained.<\/div>\n<div><span> \u2022 RAAS inhibitors do not increase hyperkalemia risk when kidney function is normal.<\/span><\/div>\n<div><\/div>\n<div>6.\u2060 \u2060Practical Clinical Recommendations<\/div>\n<div><\/div>\n<div>Safe Use (per Xu et al.):<\/div>\n<div><span> \u2022 Recommend 1:1 switch to potassium-enriched salt unless:<\/span><\/div>\n<div>\u2022\u2060\u00a0 \u2060moderate\/severe CKD (Stage \u22653)<\/div>\n<div>\u2022\u2060\u00a0 \u2060using K supplements or K-sparing diuretics<\/div>\n<div>\u2022\u2060\u00a0 \u2060other hyperkalemia risk factors<\/div>\n<div><span> \u2022 Check kidney function when feasible.<\/span><\/div>\n<div><span> \u2022 OK in mild CKD (Stage 1\u20132) with caution during acute illness.<\/span><\/div>\n<div><span> \u2022 Encourage diet rich in fruit &amp; vegetables.<\/span><\/div>\n<div><\/div>\n<div>7.\u2060 \u2060Public Health Impact<\/div>\n<div><span> \u2022 Population-wide adoption could prevent ~3 million deaths annually (modeling study).<\/span><\/div>\n<div><span> \u2022 Represents a practical, scalable lifestyle intervention with substantial global benefit.<\/span><\/div>\n<div><\/div>\n<div>8.\u2060 \u2060Key Message<\/div>\n<div><\/div>\n<div>Potassium-enriched salt is a simple, evidence-based, high-impact strategy for lowering BP and reducing cardiovascular risk \u2014 now endorsed by major hypertension guidelines and recommended for most patients without hyperkalemia risk.<\/div>\n<div><\/div>\n<div><a href=\"https:\/\/ish-world.com\/document\/1764854372.pdf\">https:\/\/ish-world.com\/document\/1764854372.pdf<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025) 1.\u2060 \u2060Background: Why Potassium-Enriched Salt? \u2022 High sodium intake remains a major global driver of hypertension, CVD, and premature death. \u2022 No country is on track to meet WHO salt-reduction targets (2025\/2030). \u2022 Low potassium intake is an under-recognized but equally important BP risk factor. \u2022 [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9351","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9351"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9351\/revisions"}],"predecessor-version":[{"id":9352,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9351\/revisions\/9352"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}